Zobrazeno 1 - 7
of 7
pro vyhledávání: '"José A Zepeda-Escobar"'
Autor:
José E Aparicio-Burgos, José A Zepeda-Escobar, Roberto Montes de Oca-Jimenez, José G Estrada-Franco, Alberto Barbabosa-Pliego, Laucel Ochoa-García, Ricardo Alejandre-Aguilar, Nancy Rivas, Giovanna Peñuelas-Rivas, Margarita Val-Arreola, Shivali Gupta, Felix Salazar-García, Nisha J Garg, Juan C Vázquez-Chagoyán
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 9, Iss 4, p e0003625 (2015)
Chagas disease, caused by Trypanosoma cruzi, is endemic in southern parts of the American continent. Herein, we have tested the protective efficacy of a DNA-prime/T. rangeli-boost (TcVac4) vaccine in a dog (Canis familiaris) model. Dogs were immunize
Externí odkaz:
https://doaj.org/article/46dfa7ef598844e58576188c53aaa662
Autor:
Nisha Jain Garg, Wael Hegazy-Hassan, Esvieta Tenorio-Borroto, Bruno Rivas-Santiago, Laucel Ochoa-García, Juan Carlos Vázquez-Chagoyán, José Esteban Aparicio-Burgos, Alberto Barbabosa-Pliego, Hector Diaz-Albiter, José Antonio Zepeda-Escobar, Rigoberto Oros-Pantoja, J.M. Eloy Contreras-Ortíz
Publikováno v:
Vaccine. 37:248-257
The efforts for the development and testing of vaccines against Trypanosoma cruzi infection have increased during the past years. We have designed a TcVac series of vaccines composed of T. cruzi derived, GPI-anchored membrane antigens. The TcVac vacc
Autor:
Juan Carlos Vázquez Chagoyán, Alberto Barbabosa Pliego, Wael Hegazy, Laucel Ochoa García, José Esteban Aparicio-Burgos, José Antonio Zepeda-Escobar, Esvieta Tenorio Borroto, Jose G. Estrada-Franco
Publikováno v:
Proceedings of MOL2NET 2016, International Conference on Multidisciplinary Sciences, 2nd edition.
Autor:
Laucel Ochoa-García, José Esteban Aparicio-Burgos, Alberto Barbabosa-Pliego, Juan Carlos Vázquez-Chagoyán, Esvieta Tenorio Borroto, Rigoberto Oros-Pantoja, José Antonio Zepeda-Escobar, José María Eloy Contreras-Ortiz, Wael Hegazy Hassan-Moustafa, María Uxúa Alonso-Fresán
Publikováno v:
Parasite, Vol 24, p 17 (2017)
Parasite
Parasite
During Trypanosoma cruzi infection, oxidative stress is considered a contributing factor for dilated cardiomyopathy development. In this study, the effects of astaxanthin (ASTX) were evaluated as an alternative drug treatment for Chagas disease in a
Autor:
Roberto Montes de Oca-Jiménez, José Antonio Zepeda-Escobar, Shivali Gupta, Nisha Jain Garg, José Simón Martínez, Juan Carlos Vázquez-Chagoyán, Laucel Ochoa-García, Margarita Val Arreola, José Esteban Aparicio-Burgos, Alberto Barbabosa-Pliego, Monisha Dhiman
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 5, Iss 5, p e1050 (2011)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Background Trypanosoma cruzi, the etiologic agent of Chagas Disease, is a major vector borne health problem in Latin America and an emerging infectious disease in the United States. Methods We tested the efficacy of a multi-component DNA-prime/DNA-bo
Autor:
Nancy Rivas, Roberto Montes de Oca-Jiménez, Nisha Jain Garg, Ricardo Alejandre-Aguilar, Margarita Val-Arreola, Jose G. Estrada-Franco, F. Salazar-García, Laucel Ochoa-García, Juan Carlos Vázquez-Chagoyán, Shivali Gupta, Giovanna Penuelas-Rivas, José Antonio Zepeda-Escobar, José Esteban Aparicio-Burgos, Alberto Barbabosa-Pliego
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 9, Iss 4, p e0003625 (2015)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases
Chagas disease, caused by Trypanosoma cruzi, is endemic in southern parts of the American continent. Herein, we have tested the protective efficacy of a DNA-prime/T. rangeli-boost (TcVac4) vaccine in a dog (Canis familiaris) model. Dogs were immunize
Autor:
José E Aparicio-Burgos, Laucel Ochoa-García, José Antonio Zepeda-Escobar, Shivali Gupta, Monisha Dhiman, José Simón Martínez, Roberto Montes de Oca-Jiménez, Margarita Val Arreola, Alberto Barbabosa-Pliego, Juan C Vázquez-Chagoyán, Nisha Jain Garg
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 5, Iss 5, p e1050 (2011)
Trypanosoma cruzi, the etiologic agent of Chagas Disease, is a major vector borne health problem in Latin America and an emerging infectious disease in the United States.We tested the efficacy of a multi-component DNA-prime/DNA-boost vaccine (TcVac1)
Externí odkaz:
https://doaj.org/article/fb0bfbc18f5e4f02b4366676719b137b